Skip to main content Accessibility help
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 43 - Melodic Intonation Therapy: The Ingredients That Make It Work

  • from Section 7 - Rhythm in Speech and Language Disabilities
  • Edited by Lars Meyer, Max Planck Institute for Human Cognitive and Brain Sciences, Antje Strauss, University of Konstanz
  • Book:
    Rhythms of Speech and Language
    Published online:
    23 April 2026
    Print publication:
    07 May 2026, pp 766-784
    • Chapter
      • You have access
      • Open access
    • PDF
    • HTML
    • Export citation

  • Summary

    Melodic intonation therapy (MIT) is a prominent music-based treatment for people with nonfluent aphasia that has numerous potentially active treatment ingredients. These include a simplified, predictable rhythm, slow rate, and unison production of spoken language. Evidence supports the effectiveness of MIT for improving repetition ability but is more modest regarding improvements in functional communication. This chapter reviews MIT’s treatment ingredients, including how they are used and how they are thought to work. With these numerous ingredients, MIT is flexible and can be customized for a particular individual’s needs, but group-level studies using standardized treatment protocols may not allow for this. A treatment taxonomy specifying treatment targets, ingredients, and mechanisms of action is a promising tool to organize the existing evidence, further investigate MIT, and implement it in clinical practice. This approach will allow for a balance between customization and standardization of the treatment protocol.